ARQT
Arcutis Biotherapeutics, Inc. · Healthcare
Director Sue-Jean Lin sold $121K of Arcutis Biotherapeutics, Inc.
Sold$120,587
$24.38Price
4,946Shares
−15%Stake
What ARQT did after the filing
- The stock from Thu, Jun 18 open, $26.69
- −2.8%
- S&P 500, same days
- +1.3%
Measured over 30 trading days, to the Aug 3 close.
Traded Mon, Jun 15. Filed Wed, Jun 17, 8:47 PM ET, after the close. Returns use the Jun 18 open and the Aug 3 close. Not investment advice.